Skip to content
Answers from the Lab cover art

All Episodes

Answers from the Lab — 390 episodes · page 1 of 4

#
Title
1

Leading Laboratory Medicine at Mayo Clinic

2

Seasonal Viruses: What To Expect and What's Next in Diagnostics

3

Closing a Diagnostic Gap for Chronic Diarrhea

4

Unlock the Full Potential of Research Data

5

A New Mindset for Leading Through Change

6

Key Components of Innovation Success

7

Better Testing for Bleeding Disorders

8

Lab Outreach Delivers Value, Growth, and Strategic Advantage

9

Personalized Therapy Growth Driven by Clinical Diagnostics

10

How Pharmacogenomics Deliver More Precise Cancer Therapy

11

Risks Increase as Ticks, Mosquitoes, and Similar Vectors Spread

12

Lab Stewardship in Modern Healthcare

13

Unique Assays Advance Care of Complex Autoimmune Skin Conditions

14

Digital Advances: What’s Next for Clinical Diagnostics?

15

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes

16

Breakthrough Test Enhances Peripheral Neuropathy Care and Research

17

How Strategic Collaborations Transform Clinical Diagnostics

18

Innovation and Resilience in Lab Logistics

19

2026 Forecast: Trends Shaping the Future of Diagnostics

20

Speed Without Sacrifice: How Diagnostics Can Move Quickly and Safely

21

Breakthroughs and Trends That Defined Lab Medicine in 2025

22

Accelerating Research and Development With BioPharma Diagnostics

23

Unlocking the Unknown With Metagenomics

24

Forging Collaborations That Deliver Better Outcomes

25

Advancing Precision Medicine Through Therapeutic Tests

26

Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D.

27

Self-Collection Testing Expands to New Areas: Elitza Theel, Ph.D.

28

Flesh-Eating Organisms Making the News: Bill Morice, M.D., Ph.D.

29

Whole Exome Sequencing Reflex Test Offers Cost-Effective Diagnosis: Cherisse Marcou, Ph.D., and Kristen Rasmussen, M.S., CGC

30

Rabbits, Chikungunya, and More Viral News: Matthew Binnicker, Ph.D.

31

The Promise, Challenges, and Global Impact of AI Tools: Bill Morice, M.D., Ph.D.

32

New Tools for the Changing Landscape of Tick-Borne Diseases: Elitza Theel, Ph.D.

33

How Investment Trends May Impact Clinical Diagnostics: Bill Morice, M.D., Ph.D.

34

Expanded assay better identifies hereditary pancreatitis: Linda Hasadsri, M.D., Ph.D., and Huong Cabral, M.S., CGC

35

How the Evolving Role of Diagnostics and Platforms Impact Healthcare: Bill Morice, M.D., Ph.D.

36

Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.

37

Assay Aids Diagnosis of Resistant Hypertension: John Lieske, M.D., and Sandra Taler, M.D.

38

Advancing Neuropathy Diagnosis With Laboratory Testing and Algorithms: Div Dubey, M.B.B.S

39

Quantitative Adenovirus Assay Better Informs Post-Transplant Care: Joseph Yao, M.D.

40

Global Diagnostic Trends and What They Mean for Laboratories: Bill Morice, M.D., Ph.D.

41

Five Ways Laboratories Maximize Health System Success: Bill Morice, M.D., Ph.D.

42

Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D.

43

Revolutionary Technology Advances Diagnosis of Neurodegenerative Disorders: Bill Morice, M.D., Ph.D.

44

Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D.

45

What Happens Next? Lab-Developed Test Rule Vacated: Bill Morice, M.D., Ph.D.

46

Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP

47

Liquid Biopsy Enables Precision Cancer Care: Bill Morice, M.D., Ph.D.

48

The Emergence of Retail Health: Bill Morice, M.D., Ph.D.

49

Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D.

50

The Impacts of STI Testing Innovation: Elitza Theel, Ph.D.

51

Why a Quality Management Program is Essential: Bill Morice, M.D., Ph.D.

52

Importance of Monitoring Business Trends in Diagnostics: Bill Morice, M.D., Ph.D.

53

Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D.

54

Innovations Set to Shape the Industry in 2025: Bill Morice, M.D., Ph.D.

55

Benefits of Automation in the Laboratory: Erin Graf, Ph.D.

56

The Latest on H5 Avian Influenza: Bill Morice, M.D., Ph.D.

57

The Rapid Evolution of Artificial Intelligence: Bill Morice, M.D., Ph.D.

58

Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D.

59

Expanding Lab Access to Improve Health Equity: Bill Morice, M.D., Ph.D.

60

Making Informed Decisions About Genetic Testing: Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC

61

Genetic Tests Identify Risk of Irinotecan-Induced Toxicity: John Logan Black, M.D.

62

What’s Causing Outbreaks of Preventable Infectious Diseases: Bill Morice, M.D., Ph.D.

63

Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D.

64

Hypermethylation Test Guides Lynch Syndrome Care: Megan Hoenig, M.S., M.P.H., CGC

65

Navigating Technology Disruptions: John Osborn

66

Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D.

67

The Science of Diagnosing Rare Platelet Disorders: Dong Chen, M.D., Ph.D.

68

Overcoming Health Threats Through Public-Private Lab Partnerships: Bill Morice, M.D., Ph.D.

69

Unique Test Screens for Recently Identified Peripheral Neuropathy: Matthew Schultz, Ph.D., and Amy White, M.S., CGC

70

Advancing Lupus Treatment With Modern Diagnostics: Bill Morice, M.D., Ph.D.

71

Panel Detects Demyelinating Neuropathy Biomarkers: John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S.

72

Novel Laboratory Tests Transform Lupus Management: Bill Morice, M.D., Ph.D.

73

Genetic Tests Identify Risk of Fluoropyrimidine-Induced Toxicity: Ann Moyer, M.D., Ph.D.

74

Breakthrough Lab Tests for Detecting Alzheimer’s Disease: Bill Morice, M.D., Ph.D.

75

Trends in the Laboratory and Diagnostic Testing Market: Bill Morice, M.D., Ph.D.

76

Why Mpox is a Public Health Emergency: Matthew Binnicker, Ph.D.

77

Tracking the Latest Pathogens: Bill Morice, M.D., Ph.D.

78

Panel Boosts Therapeutic Monitoring of IBD Drug: Maria Alice Willrich, Ph.D., and Melissa Snyder, Ph.D.

79

Global Industry Activities: Bill Morice, M.D., Ph.D.

80

Alarming Increase in Dengue Cases: Elitza Theel, Ph.D.

81

Scaling Knowledge With AI: Bill Morice, M.D., Ph.D.

82

An Impactful Supreme Court Decision: Bill Morice, M.D., Ph.D.

83

The Metals Laboratory Tests Beethoven’s Hair: Paul Jannetto, Ph.D.

84

COVID-19 and Avian Flu: Bill Morice, M.D., Ph.D.

85

The Platform Transformation of Healthcare: Bill Morice, M.D., Ph.D.

86

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D.

87

Infectious Diseases on the Move: Bill Morice, M.D., Ph.D.

88

Tests Aid Diagnosis of Cancer-Associated Neurological Disorders: Divyanshu Dubey, M.B.B.S.

89

Get to Know DLMP’s Vice Chair of Research: Peter Lucas, M.D., Ph.D.

90

Avian Flu Outbreaks and New COVID-19 Variants: Matthew Binnicker, Ph.D.

91

Enhanced Solid Tumor NGS Panel Broadens Genetic-Variants Detection: Robert Jenkins, M.D., Ph.D., Stephanie Smoley, CG(ASCP), and Beth Pitel, M.S.

92

New Panels Help Find Cause of Rapidly Progressive Dementia: Gregory (Gregg) Day, M.D.

93

Get to Know the DLMP Chair: Eric Hsi, M.D.

94

Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

95

FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

96

The Growing Crisis of Antimicrobial Resistance: Robin Patel, M.D.

97

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

98

Alzheimer’s Disease and Testing Innovations: Bill Morice, M.D., Ph.D.

99

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D

100

Lab Week and Noteworthy News: Bill Morice, M.D., Ph.D.